The Juliane Marie Center

Copenhagen, Denmark

The Juliane Marie Center

Copenhagen, Denmark
SEARCH FILTERS
Time filter
Source Type

Pearce C.L.,University of Southern California | Doherty J.A.,Fred Hutchinson Cancer Research Center | Van Den Berg D.J.,University of Southern California | Moysich K.,Roswell Park Cancer Institute | And 30 more authors.
Human Molecular Genetics | Year: 2011

The insulin-like growth factor (IGF) signaling axis plays an important role in cancer biology. We hypothesized that genetic variation in this pathway may influence risk of ovarian cancer. A three-center study of non-Hispanic whites including 1880 control women, 1135 women with invasive epithelial ovarian cancer and 321 women with borderline epithelial ovarian tumors was carried out to test the association between tag single-nucleotide polymorphisms (tSNPs) (n = 58) in this pathway and risk of ovarian cancer. We found no association between variation in IGF1, IGFBP1 or IGFBP3 and risk of invasive disease, whereas five tSNPs in IGF2 were associated with risk of invasive epithelial ovarian cancer at P < 0.05 and followed-up one of the associated SNPs. We conducted genotyping in 3216 additional non-Hispanic white cases and 5382 additional controls and were able to independently replicate our initial findings. In the combined set of studies, rs4320932 was associated with a 13% decreased risk of ovarian cancer per copy of the minor allele carried (95% confidence interval 0.81-0.93, P-trend = 7.4 × 10-5). No heterogeneity of effect across study centers was observed (phet 5 0.25). IGF2 is emerging as an important gene for ovarian cancer; additional genotyping is warranted to further confirm these associations with IGF2 and to narrow down the region harboring the causal SNP. © The Author 2011. Published by Oxford University Press. All rights reserved.

Loading The Juliane Marie Center collaborators
Loading The Juliane Marie Center collaborators